Increased FoxP3 and PD-L1 in non-pCR tissue from early stage HER2 positive breast cancer patients treated with trastuzumab-pertuzumab based regimens.

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Force, JM; Howie, LJ; Abbott, S; Bentley, RC; Marcom, PK; Kimmick, GG; Westbrook, KE; Parks, M; Topping, DL; Broadwater, G; Blackwell, KL; Nair, SK

Published Date

  • May 20, 2016

Published In

Volume / Issue

  • 34 / 15_suppl

Start / End Page

  • 602 - 602

Published By

Electronic International Standard Serial Number (EISSN)

  • 1527-7755

International Standard Serial Number (ISSN)

  • 0732-183X

Digital Object Identifier (DOI)

  • 10.1200/jco.2016.34.15_suppl.602